Immunic Inc. buy Roth Capital
Start price
07.11.25
/
50%
€0.60
Target price
07.11.26
€2.60
Performance (%)
-3.51%
Price
09.12.25
€0.58
Summary
This prediction is currently active. With a performance of -3.51%, the BUY prediction for Immunic Inc. by Roth_Capital is down slightly. This prediction currently runs until 07.11.26. The prediction end date can be changed by Roth_Capital at any time. Roth_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Immunic Inc. | 2.852% | 2.852% |
| iShares Core DAX® | 1.659% | 1.586% |
| iShares Nasdaq 100 | 0.381% | 1.900% |
| iShares Nikkei 225® | 2.102% | -1.377% |
| iShares S&P 500 | 0.221% | 1.258% |
Comments by Roth_Capital for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) is now covered by analysts at Roth Capital. They set a "buy" rating and a $3.00 price target on the stock.
Ratings data for IMUX provided by MarketBeat